Article
Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
Addiction biology - 1 Mar 2008
Kiefer Falk, Jiménez-Arriero Miguel Angel, Klein Oliver, Diehl Alexander, Rubio Gabriel
Abstract excerpt
Naltrexone is an opiate receptor antagonist mainly at the micro-receptor that is thought to reduce the positively reinforcing, pleasurable effects of alcohol and to reduce craving. An increase in time to first relapse to heavy drinking has been the most consistent finding obtained with naltrexone, although not all trials including two of the largest have been positive. Inconsistent outcome data suggest that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
